Bleeding caused by Hemophilia A

DrugDrug NameDrug Description
DB13151Anti-inhibitor coagulant complexA medication used to control bleeding episodes and prevent bleeding episodes in hemophilia A and B.
DB00036Coagulation factor VIIa Recombinant HumanA form of recombinant human coagulation Factor VII used to treat hemophilia A and B.
DB13923EmicizumabAn antibody against Factor IXa and Factor X used to treat hemophilia A.
DB13999Moroctocog alfaA recombinant Factor VIII used to treat hemophilia A to control bleeding.
DB16007Rurioctocog alfa pegolA pegylated recombinant human coagulation factor VIII used to treat and prevent bleeding episodes in patients 12 years and above with hemophilia A.
DB09108Simoctocog alfaAn antihemorrhagic agent used for the treatment and prophylaxis of bleeding in patients of all ages with haemophilia A (congenital factor VIII deficiency).
DB14738Turoctocog alfa pegolTuroctocog alfa pegol is indicated for use in adults and children with hemophilia A for on-demand treatment and control of bleeding episodes, perioperative management of bleeding, and routine prophylaxis to...
DrugDrug NameTargetType
DB13151Anti-inhibitor coagulant complexCoagulation factor Xtarget
DB13151Anti-inhibitor coagulant complexProthrombintarget
DB13151Anti-inhibitor coagulant complexFibrinogen alpha chaintarget
DB13151Anti-inhibitor coagulant complexFibrinogen beta chaintarget
DB13151Anti-inhibitor coagulant complexCoagulation factor XIII A chaintarget
DB13151Anti-inhibitor coagulant complexCoagulation factor Vtarget
DB13151Anti-inhibitor coagulant complexCoagulation factor VIIItarget
DB13151Anti-inhibitor coagulant complexCoagulation factor VIItarget
DB00036Coagulation factor VIIa Recombinant HumanCoagulation factor Xtarget
DB00036Coagulation factor VIIa Recombinant HumanTissue factortarget
DB00036Coagulation factor VIIa Recombinant HumanTissue factor pathway inhibitortarget
DB00036Coagulation factor VIIa Recombinant HumanVitamin K-dependent gamma-carboxylasetarget
DB00036Coagulation factor VIIa Recombinant HumanCoagulation factor VIItarget
DB13923EmicizumabCoagulation factor IXtarget
DB13923EmicizumabCoagulation factor Xtarget
DB13999Moroctocog alfaCoagulation factor Xtarget
DB13999Moroctocog alfaPhytanoyl-CoA dioxygenase, peroxisomaltarget
DB13999Moroctocog alfaCoagulation factor IXtarget
DB13999Moroctocog alfaAsialoglycoprotein receptor 2target
DB13999Moroctocog alfa78 kDa glucose-regulated proteintarget
DB13999Moroctocog alfaCalreticulintarget
DB13999Moroctocog alfaCalnexintarget
DB13999Moroctocog alfaProtein ERGIC-53target
DB13999Moroctocog alfaProlow-density lipoprotein receptor-related protein 1target
DB13999Moroctocog alfaMultiple coagulation factor deficiency protein 2target
DB13999Moroctocog alfavon Willebrand factortarget
DB13999Moroctocog alfaProthrombinenzyme
DB13999Moroctocog alfaVitamin K-dependent protein Cenzyme
DB16007Rurioctocog alfa pegolvon Willebrand factortarget
DB16007Rurioctocog alfa pegolCoagulation factor VIIItarget
DB09108Simoctocog alfavon Willebrand factortarget
DB14738Turoctocog alfa pegolVitamin K-dependent protein Cenzyme
DB14738Turoctocog alfa pegolCoagulation factor Xenzyme
DB14738Turoctocog alfa pegolCoagulation factor IXtarget
DB14738Turoctocog alfa pegolCoagulation factor Xtarget
DB14738Turoctocog alfa pegolProthrombintarget
DB14738Turoctocog alfa pegolvon Willebrand factortarget
DrugDrug NamePhaseStatusCount